1 | marked | 4,950 |
2 | remarkable | 1,382 |
3 | profound | 1,278 |
4 | dramatic | 1,094 |
5 | notable | 783 |
6 | striking | 576 |
7 | noticeable | 325 |
8 | drastic | 215 |
9 | steep | 202 |
10 | spectacular | 40 |
11 | treatment-dependent | 12 |
12 | atorvastatin-induced | 10 |
13 | adult-like | 8 |
14 | linewidth | 8 |
15 | fluid-induced | 7 |
16 | momentous | 7 |
17 | melatonin-induced | 5 |
18 | paradoxal | 5 |
19 | total-dose | 5 |
20 | vasodilator-induced | 5 |
21 | warming-induced | 5 |
22 | 10-ppb | 4 |
23 | 70-point | 4 |
24 | cantharidin-mediated | 4 |
25 | concentration-independent | 4 |
26 | polarity-dependent | 4 |
27 | stress-level | 4 |
28 | 1-bp | 3 |
29 | 32-mm | 3 |
30 | hze-particle-induced | 3 |
31 | less-pronounced | 3 |
32 | thermoinduced | 3 |
33 | 1.2-point | 2 |
34 | 10-db | 2 |
35 | 5.7-mmhg | 2 |
36 | aucu | 2 |
37 | bmp4-induced | 2 |
38 | compound-related | 2 |
39 | contractility-dependent | 2 |
40 | cytologic-histologic | 2 |
41 | greater-than-expected | 2 |
42 | hexose-specific | 2 |
43 | indiscernible | 2 |
44 | interchamber | 2 |
45 | interstrain | 2 |
46 | more-pronounced | 2 |
47 | postpeak | 2 |
48 | pretreatment-to-posttreatment | 2 |
49 | small/moderate | 2 |
50 | speed/accuracy | 2 |
51 | 0.07-mm | 1 |
52 | 0.22-mm | 1 |
53 | 0.24-point-steeper | 1 |
54 | 0.35ml/min/mmhg | 1 |
55 | 0.49-point-steeper | 1 |
56 | 0.58-fold | 1 |
57 | 1-3-fold | 1 |
58 | 10-50-fold | 1 |
59 | 17aag-induced | 1 |
60 | 2.38-point | 1 |
61 | 3.25-unit | 1 |
62 | 5-σ | 1 |
63 | 6.84-point | 1 |
64 | 9.6-point | 1 |
65 | class-induced | 1 |
66 | continuously-fed | 1 |
67 | d-amphetamine-related | 1 |
68 | denervational | 1 |
69 | dtt-mediated | 1 |
70 | globotriosylceramide | 1 |
71 | hp-bmd | 1 |
72 | hsr-mediated | 1 |
73 | hypothermia-a | 1 |
74 | iwt-induced | 1 |
75 | lop-sided | 1 |
76 | micromarker | 1 |
77 | one-exponential | 1 |
78 | opposite-sign | 1 |
79 | paclitaxel/mr | 1 |
80 | pathology-induced | 1 |
81 | sitaxsentan-induced | 1 |
82 | soil-dependent | 1 |
83 | strident | 1 |
84 | supine-standing | 1 |
85 | systemical | 1 |
86 | t3-like | 1 |
87 | tens-induced | 1 |
88 | tolcapone-induced | 1 |
89 | update.the | 1 |
90 | ~14-fold | 1 |
91 | ∼4-fold | 1 |
92 | ≥32-fold | 1 |
1 | 0.07-mm | 1 |
2 | 0.22-mm | 1 |
3 | 0.24-point-steeper | 1 |
4 | 0.35ml/min/mmhg | 1 |
5 | 0.49-point-steeper | 1 |
6 | 0.58-fold | 1 |
7 | 1-3-fold | 1 |
8 | 1-bp | 3 |
9 | 1.2-point | 2 |
10 | 10-50-fold | 1 |
11 | 10-db | 2 |
12 | 10-ppb | 4 |
13 | 17aag-induced | 1 |
14 | 2.38-point | 1 |
15 | 3.25-unit | 1 |
16 | 32-mm | 3 |
17 | 5-σ | 1 |
18 | 5.7-mmhg | 2 |
19 | 6.84-point | 1 |
20 | 70-point | 4 |
21 | 9.6-point | 1 |
22 | adult-like | 8 |
23 | atorvastatin-induced | 10 |
24 | aucu | 2 |
25 | bmp4-induced | 2 |
26 | cantharidin-mediated | 4 |
27 | class-induced | 1 |
28 | compound-related | 2 |
29 | concentration-independent | 4 |
30 | continuously-fed | 1 |
31 | contractility-dependent | 2 |
32 | cytologic-histologic | 2 |
33 | d-amphetamine-related | 1 |
34 | denervational | 1 |
35 | dramatic | 1,094 |
36 | drastic | 215 |
37 | dtt-mediated | 1 |
38 | fluid-induced | 7 |
39 | globotriosylceramide | 1 |
40 | greater-than-expected | 2 |
41 | hexose-specific | 2 |
42 | hp-bmd | 1 |
43 | hsr-mediated | 1 |
44 | hypothermia-a | 1 |
45 | hze-particle-induced | 3 |
46 | indiscernible | 2 |
47 | interchamber | 2 |
48 | interstrain | 2 |
49 | iwt-induced | 1 |
50 | less-pronounced | 3 |
51 | linewidth | 8 |
52 | lop-sided | 1 |
53 | marked | 4,950 |
54 | melatonin-induced | 5 |
55 | micromarker | 1 |
56 | momentous | 7 |
57 | more-pronounced | 2 |
58 | notable | 783 |
59 | noticeable | 325 |
60 | one-exponential | 1 |
61 | opposite-sign | 1 |
62 | paclitaxel/mr | 1 |
63 | paradoxal | 5 |
64 | pathology-induced | 1 |
65 | polarity-dependent | 4 |
66 | postpeak | 2 |
67 | pretreatment-to-posttreatment | 2 |
68 | profound | 1,278 |
69 | remarkable | 1,382 |
70 | sitaxsentan-induced | 1 |
71 | small/moderate | 2 |
72 | soil-dependent | 1 |
73 | spectacular | 40 |
74 | speed/accuracy | 2 |
75 | steep | 202 |
76 | stress-level | 4 |
77 | strident | 1 |
78 | striking | 576 |
79 | supine-standing | 1 |
80 | systemical | 1 |
81 | t3-like | 1 |
82 | tens-induced | 1 |
83 | thermoinduced | 3 |
84 | tolcapone-induced | 1 |
85 | total-dose | 5 |
86 | treatment-dependent | 12 |
87 | update.the | 1 |
88 | vasodilator-induced | 5 |
89 | warming-induced | 5 |
90 | ~14-fold | 1 |
91 | ∼4-fold | 1 |
92 | ≥32-fold | 1 |
1 | hypothermia-a | 1 |
2 | 10-db | 2 |
3 | 10-ppb | 4 |
4 | hexose-specific | 2 |
5 | cytologic-histologic | 2 |
6 | dramatic | 1,094 |
7 | drastic | 215 |
8 | more-pronounced | 2 |
9 | less-pronounced | 3 |
10 | bmp4-induced | 2 |
11 | fluid-induced | 7 |
12 | hze-particle-induced | 3 |
13 | tolcapone-induced | 1 |
14 | 17aag-induced | 1 |
15 | warming-induced | 5 |
16 | sitaxsentan-induced | 1 |
17 | melatonin-induced | 5 |
18 | atorvastatin-induced | 10 |
19 | vasodilator-induced | 5 |
20 | tens-induced | 1 |
21 | class-induced | 1 |
22 | iwt-induced | 1 |
23 | pathology-induced | 1 |
24 | thermoinduced | 3 |
25 | lop-sided | 1 |
26 | continuously-fed | 1 |
27 | marked | 4,950 |
28 | cantharidin-mediated | 4 |
29 | hsr-mediated | 1 |
30 | dtt-mediated | 1 |
31 | compound-related | 2 |
32 | d-amphetamine-related | 1 |
33 | greater-than-expected | 2 |
34 | 10-50-fold | 1 |
35 | ≥32-fold | 1 |
36 | 1-3-fold | 1 |
37 | ~14-fold | 1 |
38 | ∼4-fold | 1 |
39 | 0.58-fold | 1 |
40 | hp-bmd | 1 |
41 | profound | 1,278 |
42 | globotriosylceramide | 1 |
43 | update.the | 1 |
44 | t3-like | 1 |
45 | adult-like | 8 |
46 | noticeable | 325 |
47 | remarkable | 1,382 |
48 | notable | 783 |
49 | indiscernible | 2 |
50 | total-dose | 5 |
51 | small/moderate | 2 |
52 | 5.7-mmhg | 2 |
53 | 0.35ml/min/mmhg | 1 |
54 | supine-standing | 1 |
55 | striking | 576 |
56 | linewidth | 8 |
57 | postpeak | 2 |
58 | systemical | 1 |
59 | one-exponential | 1 |
60 | denervational | 1 |
61 | paradoxal | 5 |
62 | stress-level | 4 |
63 | 0.22-mm | 1 |
64 | 32-mm | 3 |
65 | 0.07-mm | 1 |
66 | opposite-sign | 1 |
67 | interstrain | 2 |
68 | 1-bp | 3 |
69 | steep | 202 |
70 | spectacular | 40 |
71 | interchamber | 2 |
72 | micromarker | 1 |
73 | 0.24-point-steeper | 1 |
74 | 0.49-point-steeper | 1 |
75 | paclitaxel/mr | 1 |
76 | momentous | 7 |
77 | 3.25-unit | 1 |
78 | strident | 1 |
79 | soil-dependent | 1 |
80 | treatment-dependent | 12 |
81 | contractility-dependent | 2 |
82 | polarity-dependent | 4 |
83 | concentration-independent | 4 |
84 | pretreatment-to-posttreatment | 2 |
85 | 70-point | 4 |
86 | 1.2-point | 2 |
87 | 6.84-point | 1 |
88 | 9.6-point | 1 |
89 | 2.38-point | 1 |
90 | aucu | 2 |
91 | speed/accuracy | 2 |
92 | 5-σ | 1 |